![Ac-[Nle4,D-Phe7]-α-MSH (4-10)-NH2](https://file.medchemexpress.com/product_pic/hy-p3662.gif "Click to View Ac-[Nle4,D-Phe7]-α-MSH (4-10)-NH2 Product Detail")
![[D-Trp8]-γ-MSH](https://file.medchemexpress.com/product_pic/hy-p1217.gif "Click to View [D-Trp8]-γ-MSH Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
88 Results for "
MSH
" in MedChemExpress (MCE) Product Catalog:
Products (88)
88 Results for "MSH" in MCE Product Catalog:
24
24 Publications Verification
Synonyms: α-Melanocyte-Stimulating Hormone
Target:
Research Areas:
Neurological Disease Metabolic Disease Inflammation/Immunology
24
24 Publications Verification
Cat. No.: HY-P0252A
CAS No.: 171869-93-5
Synonyms: α-Melanocyte-Stimulating Hormone TFA
Target:
Research Areas:
Neurological Disease Metabolic Disease Inflammation/Immunology
4
4 Cited Publications
Cat. No.: HY-P2336A
Target:
Research Areas:
2
Target:
Research Areas:
2
Target:
Research Areas:
2
Target:
Research Areas:
McN-A-343 is a selective M1 muscarinic agonist that stimulates muscarinic transmission in sympathetic ganglia. McN-A-343 produces a significant inhibitory effect on Muscarine (HY-121404)-evoked catecholamine secretion from the isolated perfused rat adrenal gland. McN-A-343 is involved in the regulation of neuronal firing and activates enteroendocrine L cells to release glucagon-like peptide 1 (GLP-1) and modulates the secretion of α-melanocyte stimulating hormone (α-MSH) from the pituitary gland in the central nervous system. McN-A-343 reduces colonic inflammation and oxidative stress in Acetic acid (HY-Y0319)-induced ulcerative colitis (UC) mice. McN-A-343 can be used for the study of ulcerative colitis .
1
Target:
Research Areas:
Metabolic Disease Inflammation/Immunology Endocrinology Cancer
1
1 Cited Publications
Cat. No.: HY-P1531
CAS No.: 72629-65-3
Target:
Research Areas:
1
1 Cited Publications
Cat. No.: HY-N2466A
CAS No.: 1566590-77-9
Synonyms: MT-I acetate; [Nle4,D-Phe7]-α-MSH acetate
Target:
Research Areas:
Metabolic Disease Inflammation/Immunology Endocrinology Cancer
Target:
Research Areas:
JNJ-10229570 is an antagonist of melanocortin receptor 1 (MC1R) and melanocortin receptor 5 (MC5R), which inhibits sebaceous gland differentiation and the production of sebum-specific lipids. JNJ-10229570 inhibits the binding of 125I-NDP-α-MSH to cells expressing human MC1R and MC5R, with IC50 values of 270 nM and 200 nM, respectively.
Cat. No.: HY-129724A
CAS No.: 2828433-34-5
Synonyms: ACTH-(11-13) acetate; Lys-Pro-Val acetate; H-Lys-Pro-Val-OH acetate
Research Areas:
Infection Neurological Disease Metabolic Disease Inflammation/Immunology
Cat. No.: HY-P3662
CAS No.: 82188-67-8
Target:
Research Areas:
Cat. No.: HY-P5247
Synonyms: PTP20
Target:
Research Areas:
Cat. No.: HY-P11290
CAS No.: 1228015-10-8
Target:
Research Areas:
Cat. No.: HY-P1213
CAS No.: 436083-30-6
Target:
Research Areas:
Cat. No.: HY-P1214
CAS No.: 72629-65-3
Target:
Research Areas:
Cat. No.: HY-P1217
CAS No.: 321351-81-9
Target:
Research Areas:
Cat. No.: HY-P1504
CAS No.: 17908-57-5
Synonyms: Beta-MSH (1-22) (human)
Target:
Research Areas:
Cat. No.: HY-129724
CAS No.: 67727-97-3
Synonyms: ACTH-(11-13); Lys-Pro-Val; H-Lys-Pro-Val-OH
Research Areas:
Infection Neurological Disease Metabolic Disease Inflammation/Immunology
Cat. No.: HY-P1504A
Synonyms: Beta-MSH (1-22) (human) TFA
Target:
Research Areas:
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
